home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

New Cholesterol-Lowering Drugs Discovered

  December, 3 2001 9:34
your information resource in human molecular genetics
High plasma levels of low-density lipoprotein (LDL) cholesterol is a risk factor for atherosclerosis and ultimately coronary heart disease. The statin drugs, such as Pfizer's lipitor, are highly effective at lowering levels of this lipid in some patients and have spurred the search for other compounds that can reduce LDL levels to within the desired range.

In this issue of Nature Medicine, Thierry Grand-Perret and colleagues from GlaxoSmithKline Pharmaceuticals report on the identification of a novel class of compounds that lower cholesterol levels via a different mechanism to the statin drugs. These compounds bind to a sterol regulating protein that goes by the acronym, SCAP, and causes an increase in the number of a receptor for LDL which speeds up the removal of cholesterol from the plasma.

In an accompanying News & Views article, Daniel Rader of University of Pennsylvania School of Medicine explains how the new compounds work at the molecular level and remarks, "…several new approaches to reduction of plasma LDL cholesterol are likely to be introduced over the next decade."

Author contact:
Dr. Thierry Grand-Perret
GlaxoSmithKline Pharmaceuticals
91951 Les Ulis cedex
Phone: +33 1-69-29-60-00
Email: tgp28876@gsk.com

Dr. Daniel J. Rader
University of Pennsylvania School of Medicine
422 Curie Boulevard
Philadelphia, PA 19104
Phone: +1 215 662-9097
Fax: +1 215 573 8606
Email: rader@mail.med.upenn.edu

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.